Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2012
Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweAndrea L Ciaranello, Freddy Perez, Barbara Engelsmann, et al.
BMJ Global Health|December 15, 2024
The impact of tobacco smoking and smoking cessation on lung cancer and stroke incidence among people with HIV on antiretroviral therapy in South Africa: a simulation modeling studyHelen D'Couto, Acadia M Thielking, Ronel Sewpaul, et al.
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.
The European Respiratory Journal|May 4, 2019
Detection, survival and infectious potential of <i>Mycobacterium tuberculosis</i> in the environment: a review of the evidence and epidemiological implicationsLeonardo Martinez, Renu Verma, Julio Croda, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Cost-Effectiveness of Community Tuberculosis Screening in South AfricaJulie N Deleger, S Nazanin Khatami, Michelle Jones, et al.
Plos One|May 30, 2020
Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmissionPatience Nyakato, Mary-Ann Davies, Karl-Gunter Technau, et al.
The Journal of Infectious Diseases|May 14, 2008
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study, Sean Emery, Jacqueline A Neuhaus, et al.
Tropical Medicine & International Health : TM & IH|December 4, 2012
Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern AfricaLukas Fenner, Stewart E Reid, Matthew P Fox, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic SuppressionMary-Ann Davies, Nathan Ford, Helena Rabie, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2012
Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweAndrea L Ciaranello, Freddy Perez, Barbara Engelsmann, et al.
BMJ Global Health|December 15, 2024
The impact of tobacco smoking and smoking cessation on lung cancer and stroke incidence among people with HIV on antiretroviral therapy in South Africa: a simulation modeling studyHelen D'Couto, Acadia M Thielking, Ronel Sewpaul, et al.
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.
The European Respiratory Journal|May 4, 2019
Detection, survival and infectious potential of <i>Mycobacterium tuberculosis</i> in the environment: a review of the evidence and epidemiological implicationsLeonardo Martinez, Renu Verma, Julio Croda, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Cost-Effectiveness of Community Tuberculosis Screening in South AfricaJulie N Deleger, S Nazanin Khatami, Michelle Jones, et al.
Plos One|May 30, 2020
Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmissionPatience Nyakato, Mary-Ann Davies, Karl-Gunter Technau, et al.
The Journal of Infectious Diseases|May 14, 2008
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study, Sean Emery, Jacqueline A Neuhaus, et al.
Tropical Medicine & International Health : TM & IH|December 4, 2012
Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern AfricaLukas Fenner, Stewart E Reid, Matthew P Fox, et al.
The Pediatric Infectious Disease Journal|September 18, 2015
Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic SuppressionMary-Ann Davies, Nathan Ford, Helena Rabie, et al.
Pageof 37